西点药业
(301130)
| 流通市值：15.95亿 | | | 总市值：20.67亿 |
| 流通股本：5901.74万 | | | 总股本：7649.47万 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 101,427,291.82 | 55,925,260.77 | 234,840,419.16 | 188,945,385.6 |
| 营业总成本 | 97,477,784.53 | 48,180,633.12 | 222,490,004.98 | 159,135,919.32 |
| 其他经营收益 | | | | |
| 营业利润 | 8,086,404.94 | 9,790,780.82 | 20,220,762.41 | 36,102,449.42 |
| 利润总额 | 8,030,556.3 | 9,963,428.72 | 20,996,168.44 | 36,164,443.4 |
| 净利润 | 7,822,214.56 | 8,602,728.43 | 19,898,052.57 | 31,352,268.69 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 7,822,214.56 | 8,602,728.43 | 19,898,052.57 | 31,352,268.69 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 333,900,035.91 | 330,140,522.36 | 342,861,833.03 | 355,329,939.54 |
| 非流动资产: | | | | |
| 非流动资产合计 | 731,443,709.45 | 717,241,473.53 | 718,717,971.9 | 697,827,861.06 |
| 资产总计 | 1,065,343,745.36 | 1,047,381,995.89 | 1,061,579,804.93 | 1,053,157,800.6 |
| 流动负债: | | | | |
| 流动负债合计 | 100,275,140.31 | 69,854,579.96 | 88,421,168.44 | 56,395,630.79 |
| 非流动负债: | | | | |
| 非流动负债合计 | 64,298,935.68 | 65,302,205.28 | 38,377,482.69 | 49,340,003.4 |
| 负债合计 | 164,574,075.99 | 135,156,785.24 | 126,798,651.13 | 105,735,634.19 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 871,364,856.6 | 882,297,477.9 | 904,271,319.66 | 916,731,759.27 |
| 股东权益合计 | 900,769,669.37 | 912,225,210.65 | 934,781,153.8 | 947,422,166.41 |
| 负债和股东权益合计 | 1,065,343,745.36 | 1,047,381,995.89 | 1,061,579,804.93 | 1,053,157,800.6 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 122,739,900.99 | 65,715,022.18 | 276,284,023.98 | 208,422,045.09 |
| 经营活动现金流出小计 | 95,025,414.03 | 50,753,935.29 | 227,662,778.42 | 169,912,020.87 |
| 经营活动产生的现金流量净额 | 27,714,486.96 | 14,961,086.89 | 48,621,245.56 | 38,510,024.22 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 320,587,670.76 | 217,092,009.3 | 956,777,408.74 | 782,969,559.17 |
| 投资活动现金流出小计 | 251,564,662.5 | 214,416,962.9 | 1,142,421,936.52 | 901,437,701.01 |
| 投资活动产生的现金流量净额 | 69,023,008.26 | 2,675,046.4 | -185,644,527.78 | -118,468,141.84 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 30,725,000 | 30,125,000 | 11,530,000 | 10,000,000 |
| 筹资活动现金流出小计 | 44,606,617.41 | 33,258,493.19 | 35,676,332.55 | 35,438,910.3 |
| 筹资活动产生的现金流量净额 | -13,881,617.41 | -3,133,493.19 | -24,146,332.55 | -25,438,910.3 |
| 汇率变动对现金及现金等价物的影响 | - | - | - | - |
| 现金及现金等价物净增加额 | 82,855,877.81 | 14,502,640.1 | -161,169,614.77 | -105,397,027.92 |
| 期末现金及现金等价物余额 | 111,803,656.96 | 43,450,419.25 | 28,947,779.15 | 84,720,366 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 82,855,877.81 | - | -161,169,614.77 | - |